Table 1.

Baseline characteristics of the control and stroke cohorts.

	Stroke cohort	Control cohort	p-value
	n = 62	n = 43
Age (years)	57.59 ± 9.7	60.8 ± 10.8	0.11
Sex, males	79.7 (51)	20.3 (13)	<0.01
Risk factors and comorbidities
Alcohol	27.4 (17)	23.8 (10)	0.65
Tobacco	37.1 (23)	16.7 (7)	0.02
Atrial fibrillation	9.7 (6)	0 (0)	0.07
Hypertension	61.3 (38)	46.5 (20)	0.16
Dyslipidemia	40.3 (25)	46.5 (20)	0.52
Diabetes mellitus	19.7 (12)	18.6 (8)	0.89
Obesity	29.5 (18)	34.9 (15)	0.56
Previous exercise	39.0 (23)	76.7 (33)	<0.001
Cardiopathy	6.5 (4)	0 (0.0)	0.14
Osteoarticular	12.9 (8)	32 (14)	0.01
Psychiatric	16.1 (10)	9.3 (4)	0.31
Previous medication
Anti-platelets	21 (13)	14.3 (6)	0.38
Anti-coagulants	4.8 (3)	0 (0.0)	0.27
Statins	38.7 (24)	28.6 (12)	0.28
Anti-hypertensives	53.2 (33)	40.5 (17)	0.2
Anti-diabetic	17.7 (11)	14.3 (6)	0.64
Angiogenin
Baseline levels (ng/mL)	520.8 ± 139.2	432.8 ± 155.7	<0.01

Variables are expressed as a percentage (number of cases, n) or mean ± SD. Differences were assessed with a t-test, chi-square test, or Fisher exact test.

Statistically significant differences are highlighted in bold.